The Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” is an Italian IRCCS (institute for hospitalisation and care of a scientific nature) dedicated to treatment, research, and training in the field of oncology.
The Alma Mater Studiorum – Università di Bologna is considered as the first university in the western world. UNIBO explores advanced teaching methods, adapting to the dynamics of educational developments to provide effective and relevant responses to people’s growing needs.
The Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe. Both basic research and application-related clinical research are developed by the CHR through interdisciplinary networking.
The Cyprus Institute of Neurology & Genetics is dedicated to lessening the suffering of patients and their families and preventing diseases through patient care, research and educational programs on neurological and genetic conditions.
The CzEch Leukemia Study Group – for Life aims at improving care for patients suffering from leukemias in the Czech Republic and accelerating research in this field.
The ELN Foundation is a charity that supports the activities and the members of European LeukemiaNet (ELN), an international network promoting cooperative research for curing leukemia.
The Fondazione GIMEMA – Franco Mandelli ONLUS conducts and coordinates independent clinical studies in the field of haematological diseases of adults in order to improve the standard of care for patients suffering from blood diseases.
The Fondazione Toscana Life Sciences is a not for profit research organisation and engaged in in-house research activities and in business incubation, acting as aggregator and facilitator of an innovation ecosystem in the health and biotechnology sector, placing itself at the center of a national and international network comprising both public and private partnerships.
Fundación del Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), which operates through its Institute for Biomedical Research of Salamanca (IBSAL), support the clinical and basic research to address key challenges in health and medicine, fostering collaboration between hospitals and universities to improve patient care through scientific innovation.
The purpose of the Gesellschaft für Pädiatrische Onkologie und Hämatologie gGmbH is to promote public health, in particular research into the nature, diagnosis and treatment of childhood and adolescent tumours and blood diseases and to improve the necessary structures.
The Health Research Institute La Fe carries out scientific and research activities with multidisciplinary and complementary research groups that have consolidated expertise in cellular and molecular biology, cell culture, functional analysis imaging, “omics” and clinical research.
The Hospital of Lithuanian University of Health Sciences Kauno klinikos is the largest healthcare institution in Lithuania. The hospital has 39 departments devoted to all medical and surgical specialties, including cardiovascular surgery, neurosurgery, and organ transplant surgery.
The Martin Luther University Halle-Wittenberg offers a wide range of academic subjects in the areas of humanities, social sciences, natural sciences and medicine.
The Ospedale Pediatrico Bambino Gesù is the largest paediatric polyclinic and research centre in Europe. Connected to major international centres in the field, it is a point of reference for the health of children and young people from all over Italy and abroad.
The Ostdeutsche Studiengruppe e. V. conducts clinical studies to improve the detection and treatment of leukaemia, other blood diseases and solid tumours.
Timelex is a leading niche law firm specialised in the legal aspects of information technology (IT), privacy & data protection (GDPR), intellectual property, and media & electronic communications.
The Vall d’Hebron Research Institute is a Spanish public sector institution that promotes and develops biomedical research, innovation, and teaching at Vall d’Hebron University Hospital.
The Acute Leukemia Advocates Network is an independent global network of patient organisations, dedicated to changing outcomes of patients with acute leukemias by strengthening patient advocacy in that area.